SE0301816L - Combined doses - Google Patents

Combined doses

Info

Publication number
SE0301816L
SE0301816L SE0301816A SE0301816A SE0301816L SE 0301816 L SE0301816 L SE 0301816L SE 0301816 A SE0301816 A SE 0301816A SE 0301816 A SE0301816 A SE 0301816A SE 0301816 L SE0301816 L SE 0301816L
Authority
SE
Sweden
Prior art keywords
combined doses
doses
combined
Prior art date
Application number
SE0301816A
Other languages
Swedish (sv)
Other versions
SE0301816D0 (en
SE526850C2 (en
Inventor
Thomas Nilsson
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdrug Ag filed Critical Microdrug Ag
Priority to SE0301816A priority Critical patent/SE526850C2/en
Publication of SE0301816D0 publication Critical patent/SE0301816D0/en
Priority to US10/603,818 priority patent/US20040258624A1/en
Priority to SE0302939A priority patent/SE527200C2/en
Priority to US10/703,505 priority patent/US20050053553A1/en
Priority to SE0303050A priority patent/SE527190C2/en
Priority to SE0303091A priority patent/SE527191C2/en
Priority to SE0303128A priority patent/SE527189C2/en
Priority to SE0303375A priority patent/SE526509C2/en
Priority to CA002528863A priority patent/CA2528863A1/en
Priority to CA002529127A priority patent/CA2529127A1/en
Priority to EP04749003A priority patent/EP1696882A1/en
Priority to AU2004246990A priority patent/AU2004246990A1/en
Priority to EP04749002A priority patent/EP1691839A1/en
Priority to PCT/SE2004/000953 priority patent/WO2004110491A1/en
Priority to PCT/SE2004/000954 priority patent/WO2004110404A1/en
Priority to ZA200600561A priority patent/ZA200600561B/en
Priority to ZA200600560A priority patent/ZA200600560B/en
Priority to AU2004246989A priority patent/AU2004246989A1/en
Priority to US10/870,907 priority patent/US20050042174A1/en
Priority to US10/870,945 priority patent/US20050063911A1/en
Priority to US10/870,909 priority patent/US20050042175A1/en
Publication of SE0301816L publication Critical patent/SE0301816L/en
Publication of SE526850C2 publication Critical patent/SE526850C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0301816A 2003-06-19 2003-06-19 Pharmaceutical combined dry powder dose separated on common dose bed SE526850C2 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE0301816A SE526850C2 (en) 2003-06-19 2003-06-19 Pharmaceutical combined dry powder dose separated on common dose bed
US10/603,818 US20040258624A1 (en) 2003-06-19 2003-06-26 Combined doses
SE0302939A SE527200C2 (en) 2003-06-19 2003-11-06 Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
US10/703,505 US20050053553A1 (en) 2003-06-19 2003-11-10 Combined doses of formoterol and fluticasone
SE0303050A SE527190C2 (en) 2003-06-19 2003-11-17 Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE0303091A SE527191C2 (en) 2003-06-19 2003-11-18 Inhaler device and combined doses of tiotropium and fluticasone
SE0303128A SE527189C2 (en) 2003-06-19 2003-11-21 Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE0303375A SE526509C2 (en) 2003-06-19 2003-12-12 Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
AU2004246989A AU2004246989A1 (en) 2003-06-19 2004-06-15 Combined doses
EP04749003A EP1696882A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
ZA200600561A ZA200600561B (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
CA002528863A CA2528863A1 (en) 2003-06-19 2004-06-15 Combined doses
AU2004246990A AU2004246990A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
EP04749002A EP1691839A1 (en) 2003-06-19 2004-06-15 Combined doses
PCT/SE2004/000953 WO2004110491A1 (en) 2003-06-19 2004-06-15 Combined doses
PCT/SE2004/000954 WO2004110404A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
CA002529127A CA2529127A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
ZA200600560A ZA200600560B (en) 2003-06-19 2004-06-15 Combined doses
US10/870,909 US20050042175A1 (en) 2003-06-19 2004-06-21 Combined doses of formoterol and budesonide
US10/870,907 US20050042174A1 (en) 2003-06-19 2004-06-21 Combined doses
US10/870,945 US20050063911A1 (en) 2003-06-19 2004-06-21 Combined doses of formoterol and an anticholinergic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301816A SE526850C2 (en) 2003-06-19 2003-06-19 Pharmaceutical combined dry powder dose separated on common dose bed

Publications (3)

Publication Number Publication Date
SE0301816D0 SE0301816D0 (en) 2003-06-19
SE0301816L true SE0301816L (en) 2004-12-20
SE526850C2 SE526850C2 (en) 2005-11-08

Family

ID=27607381

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301816A SE526850C2 (en) 2003-06-19 2003-06-19 Pharmaceutical combined dry powder dose separated on common dose bed

Country Status (7)

Country Link
US (1) US20040258624A1 (en)
EP (1) EP1691839A1 (en)
AU (1) AU2004246989A1 (en)
CA (1) CA2528863A1 (en)
SE (1) SE526850C2 (en)
WO (1) WO2004110491A1 (en)
ZA (2) ZA200600561B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527189C2 (en) * 2003-06-19 2006-01-17 Microdrug Ag Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE527190C2 (en) * 2003-06-19 2006-01-17 Microdrug Ag Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE526509C2 (en) * 2003-06-19 2005-09-27 Microdrug Ag Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE0303570L (en) * 2003-12-03 2005-06-04 Microdrug Ag Moisture-sensitive medical product
AU2010260513A1 (en) * 2009-06-16 2012-02-02 Wen Tan Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
CZ288032B6 (en) * 1991-12-18 2001-04-11 Aktiebolaget Astra Pharmaceutical preparation intended for administration by inhalation
US5437267A (en) * 1993-08-03 1995-08-01 Weinstein; Allan Device for delivering aerosol to the nasal membranes and method of use
DE19541594A1 (en) * 1995-11-08 1997-05-15 Pfeiffer Erich Gmbh & Co Kg Discharge unit for media
SE9700135D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
FI107126B (en) * 1999-04-23 2001-06-15 Orion Yhtymae Oyj Powder inhaler for combination medicine
FI108518B (en) * 1999-04-23 2002-02-15 Orion Yhtymae Oyj Powder inhaler for combination medicine
GB9928265D0 (en) * 1999-12-01 2000-01-26 Innovata Biomed Ltd Inhaler
US6369115B1 (en) * 2000-03-20 2002-04-09 Dura Pharmaceuticals, Inc. Stabilized powder formulations
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
SE517229C2 (en) * 2000-09-25 2002-05-14 Microdrug Ag Continuous dry powder inhaler
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
EP1387656B1 (en) * 2001-04-19 2009-12-23 Technology Innovation Limited Medicament container
GB0201677D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
EP1487407A4 (en) * 2002-03-12 2010-08-25 Microdose Therapeutx Inc Site specific delivery of co-administered drugs via inhalation
SE527200C2 (en) * 2003-06-19 2006-01-17 Microdrug Ag Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE526509C2 (en) * 2003-06-19 2005-09-27 Microdrug Ag Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE527190C2 (en) * 2003-06-19 2006-01-17 Microdrug Ag Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE527189C2 (en) * 2003-06-19 2006-01-17 Microdrug Ag Administration of metered dry powder combined doses of finely divided dry medication powders involves selecting first and second medicaments for forming of pharmaceutical, combined doses
SE527069C2 (en) * 2003-06-19 2005-12-13 Mederio Ag Method and apparatus for administering drug powder

Also Published As

Publication number Publication date
SE0301816D0 (en) 2003-06-19
CA2528863A1 (en) 2004-12-23
EP1691839A1 (en) 2006-08-23
ZA200600561B (en) 2007-04-25
SE526850C2 (en) 2005-11-08
ZA200600560B (en) 2007-04-25
WO2004110491A1 (en) 2004-12-23
US20040258624A1 (en) 2004-12-23
AU2004246989A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
DE50305213D1 (en) DOSING
DE602004022685D1 (en) DISPENSER
DE60310919D1 (en) DOSING
NO20054103D0 (en) dispensing arrangements
FI6928U1 (en) slots
DK1611884T3 (en) PLASTER, CONTAINING DICLOFENAC
DE602004011420D1 (en) Simplified size meter
DE602004004736D1 (en) shampoo
DE50309835D1 (en) metering
DE602004022810D1 (en) MORE DOSE INHALER
DE502004009346D1 (en) seeder
DE50311317D1 (en) DOSING
FR2843798B1 (en) DOSING MACHINE
DE50309094D1 (en) DOSING
SE0301816L (en) Combined doses
DE602004004266D1 (en) POWDER DISPENSER
ITFI20030299A1 (en) ORTHODONTIC MICROVITE.
DE502004006944D1 (en) DOSING
DE50301675D1 (en) metering
FI20031158A0 (en) Inhalator
ITMI20041742A1 (en) DOSER BOTTLE
DE50304219D1 (en) metering
ITTO20030224A1 (en) DOSER DEVICE
FIU20030483U0 (en) Interactive drug doser
DE102004027555B8 (en) packaging

Legal Events

Date Code Title Description
NUG Patent has lapsed
NUG Patent has lapsed